Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC, Haugen BR.

J Clin Endocrinol Metab. 2008 Nov;93(11):4331-41. doi: 10.1210/jc.2008-1102. Epub 2008 Aug 19.

2.

Thyroid cancer cell line misidentification: an update.

Schweppe RE.

J Clin Endocrinol Metab. 2013 Mar;98(3):956-7. doi: 10.1210/jc.2012-4182. No abstract available.

3.

Misidentification of putative medullary thyroid cancer cell lines RO-H85-1 and RO-D81-1.

Dadon T, Ball D, Nelkin BD.

J Clin Endocrinol Metab. 2013 Mar;98(3):954-5. doi: 10.1210/jc.2012-4181. No abstract available.

PMID:
23472229
4.

Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines.

Meireles AM, Preto A, Rocha AS, Rebocho AP, Máximo V, Pereira-Castro I, Moreira S, Feijão T, Botelho T, Marques R, Trovisco V, Cirnes L, Alves C, Velho S, Soares P, Sobrinho-Simões M.

Thyroid. 2007 Aug;17(8):707-15.

PMID:
17725429
5.

Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line.

Korch C, Hall EM, Dirks WG, Ewing M, Faries M, Varella-Garcia M, Robinson S, Storts D, Turner JA, Wang Y, Burnett EC, Healy L, Kniss D, Neve RM, Nims RW, Reid YA, Robinson WA, Capes-Davis A.

Int J Cancer. 2018 Feb 1;142(3):561-572. doi: 10.1002/ijc.31067. Epub 2017 Oct 10.

6.

MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research.

Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD.

Breast Cancer Res Treat. 2007 Jul;104(1):13-9. Epub 2006 Sep 27.

PMID:
17004106
7.

SNP array profiling of mouse cell lines identifies their strains of origin and reveals cross-contamination and widespread aneuploidy.

Didion JP, Buus RJ, Naghashfar Z, Threadgill DW, Morse HC 3rd, de Villena FP.

BMC Genomics. 2014 Oct 3;15:847. doi: 10.1186/1471-2164-15-847.

8.

Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.

McCarty SK, Saji M, Zhang X, Jarjoura D, Fusco A, Vasko VV, Ringel MD.

Endocr Relat Cancer. 2010 Oct 29;17(4):989-99. doi: 10.1677/ERC-10-0168. Print 2010 Dec.

9.

The metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma.

McCorkle JR, Leonard MK, Kraner SD, Blalock EM, Ma D, Zimmer SG, Kaetzel DM.

Cancer Genomics Proteomics. 2014 Jul-Aug;11(4):175-94.

10.

Thyroid cancer cell lines: an overview.

Saiselet M, Floor S, Tarabichi M, Dom G, Hébrant A, van Staveren WC, Maenhaut C.

Front Endocrinol (Lausanne). 2012 Nov 16;3:133. doi: 10.3389/fendo.2012.00133. eCollection 2012.

11.

Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.

Akaishi J, Onda M, Okamoto J, Miyamoto S, Nagahama M, Ito K, Yoshida A, Shimizu K.

BMC Cancer. 2006 Nov 1;6:260.

12.

Expression of human beta-defensins-1-4 in thyroid cancer cells and new insight on biologic activity of hBD-2 in vitro.

Zhuravel OV, Gerashchenko OL, Khetsuriani MR, Soldatkina MA, Pogrebnoy PV.

Exp Oncol. 2014 Sep;36(3):174-8.

PMID:
25265350
13.

Characterization of thyroid cancer cell lines in murine orthotopic and intracardiac metastasis models.

Morrison JA, Pike LA, Lund G, Zhou Q, Kessler BE, Bauerle KT, Sams SB, Haugen BR, Schweppe RE.

Horm Cancer. 2015 Jun;6(2-3):87-99. doi: 10.1007/s12672-015-0219-0. Epub 2015 Mar 24.

14.

Clonally related but phenotypically divergent human cancer cell lines derived from a single follicular thyroid cancer recurrence (TT2609).

Geldof AA, Versteegh LRT, van Mourik JC, Rooimans MA, Arwert F, Hermsen MA, Schadee-Eestermans IL, van Dongen GA, van der Valk P, van der Clement EHP, Lips P, Teule GJ.

Thyroid. 2001 Oct;11(10):909-17.

PMID:
11716037
15.

Development and characterization of six new human papillary thyroid carcinoma cell lines.

Henderson YC, Ahn SH, Ryu J, Chen Y, Williams MD, El-Naggar AK, Gagea M, Schweppe RE, Haugen BR, Lai SY, Clayman GL.

J Clin Endocrinol Metab. 2015 Feb;100(2):E243-52. doi: 10.1210/jc.2014-2624. Epub 2014 Nov 26.

16.

Differential pattern of integrin receptor expression in differentiated and anaplastic thyroid cancer cell lines.

Hoffmann S, Maschuw K, Hassan I, Reckzeh B, Wunderlich A, Lingelbach S, Zielke A.

Thyroid. 2005 Sep;15(9):1011-20.

PMID:
16187909
17.

Aberrant promoter methylation in overexpression of CITED1 in papillary thyroid cancer.

Sassa M, Hayashi Y, Watanabe R, Kikumori T, Imai T, Kurebayashi J, Kiuchi T, Murata Y.

Thyroid. 2011 May;21(5):511-7. doi: 10.1089/thy.2010.0295. Epub 2011 Mar 30.

PMID:
21449767
18.

Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.

Ulivieri A, Lavra L, Dominici R, Giacomelli L, Brunetti E, Sciacca L, Trovato M, Barresi G, Foukakis T, Jia-Jing L, Larsson C, Bartolazzi A, Sciacchitano S.

J Pathol. 2008 May;215(1):87-96. doi: 10.1002/path.2331.

PMID:
18306168
19.

Detection of mutations in the DNA polymerase delta gene of human sporadic colorectal cancers and colon cancer cell lines.

Flohr T, Dai JC, Büttner J, Popanda O, Hagmüller E, Thielmann HW.

Int J Cancer. 1999 Mar 15;80(6):919-29.

20.

Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis.

Subramanian M, Pilli T, Bhattacharya P, Pacini F, Nikiforov YE, Kanteti PV, Prabhakar BS.

J Clin Endocrinol Metab. 2009 Apr;94(4):1467-71. doi: 10.1210/jc.2008-2378. Epub 2009 Feb 3.

Supplemental Content

Support Center